instruction stringlengths 34 186 | input stringlengths 2.02k 93.8k | output stringlengths 2 418 | meta_questiontype stringclasses 6
values | meta_inputlicense stringclasses 6
values | meta_pmid stringlengths 8 8 | meta_safetyreportid int64 9.51M 21M | meta_articlepubdate stringlengths 4 10 |
|---|---|---|---|---|---|---|---|
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Immune-mediated lung disease'. | Patterns of immunotherapy-induced pneumonitis in patients with non-small-cell lung cancer: a case series.
BACKGROUND
Immunotherapy has become an efficacious option in the management of solid organ malignancies. Immune-related adverse events including pneumonitis are well described and may be particularly of concern in ... | CARBOPLATIN, CYCLOPHOSPHAMIDE, DOXYCYCLINE, DURVALUMAB, METHYLPREDNISOLONE, PACLITAXEL, PREDNISOLONE | DrugsGivenReaction | CC BY | 34215343 | 19,635,780 | 2021-07-03 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Off label use'. | Patterns of immunotherapy-induced pneumonitis in patients with non-small-cell lung cancer: a case series.
BACKGROUND
Immunotherapy has become an efficacious option in the management of solid organ malignancies. Immune-related adverse events including pneumonitis are well described and may be particularly of concern in ... | CARBOPLATIN, CYCLOPHOSPHAMIDE, DOXYCYCLINE, DURVALUMAB, METHYLPREDNISOLONE, PACLITAXEL, PREDNISOLONE | DrugsGivenReaction | CC BY | 34215343 | 19,635,780 | 2021-07-03 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Pneumonitis'. | Patterns of immunotherapy-induced pneumonitis in patients with non-small-cell lung cancer: a case series.
BACKGROUND
Immunotherapy has become an efficacious option in the management of solid organ malignancies. Immune-related adverse events including pneumonitis are well described and may be particularly of concern in ... | AZITHROMYCIN ANHYDROUS, CARBOPLATIN, CEFEPIME HYDROCHLORIDE, GEMCITABINE, MEROPENEM, METHYLPREDNISOLONE, SULFAMETHOXAZOLE\TRIMETHOPRIM | DrugsGivenReaction | CC BY | 34215343 | 19,663,973 | 2021-07-03 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Rebound effect'. | Patterns of immunotherapy-induced pneumonitis in patients with non-small-cell lung cancer: a case series.
BACKGROUND
Immunotherapy has become an efficacious option in the management of solid organ malignancies. Immune-related adverse events including pneumonitis are well described and may be particularly of concern in ... | CARBOPLATIN, CYCLOPHOSPHAMIDE, DOXYCYCLINE, DURVALUMAB, METHYLPREDNISOLONE, PACLITAXEL, PREDNISOLONE | DrugsGivenReaction | CC BY | 34215343 | 19,635,780 | 2021-07-03 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Therapeutic product effect incomplete'. | Patterns of immunotherapy-induced pneumonitis in patients with non-small-cell lung cancer: a case series.
BACKGROUND
Immunotherapy has become an efficacious option in the management of solid organ malignancies. Immune-related adverse events including pneumonitis are well described and may be particularly of concern in ... | AZITHROMYCIN ANHYDROUS, CARBOPLATIN, CEFEPIME HYDROCHLORIDE, GEMCITABINE, MEROPENEM, METHYLPREDNISOLONE, SULFAMETHOXAZOLE\TRIMETHOPRIM | DrugsGivenReaction | CC BY | 34215343 | 19,663,973 | 2021-07-03 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Therapy partial responder'. | Patterns of immunotherapy-induced pneumonitis in patients with non-small-cell lung cancer: a case series.
BACKGROUND
Immunotherapy has become an efficacious option in the management of solid organ malignancies. Immune-related adverse events including pneumonitis are well described and may be particularly of concern in ... | CARBOPLATIN, CYCLOPHOSPHAMIDE, DOXYCYCLINE, DURVALUMAB, METHYLPREDNISOLONE, PACLITAXEL, PREDNISOLONE | DrugsGivenReaction | CC BY | 34215343 | 19,635,780 | 2021-07-03 |
What was the administration route of drug 'AZITHROMYCIN ANHYDROUS'? | Patterns of immunotherapy-induced pneumonitis in patients with non-small-cell lung cancer: a case series.
BACKGROUND
Immunotherapy has become an efficacious option in the management of solid organ malignancies. Immune-related adverse events including pneumonitis are well described and may be particularly of concern in ... | Intravenous (not otherwise specified) | DrugAdministrationRoute | CC BY | 34215343 | 19,628,465 | 2021-07-03 |
What was the administration route of drug 'CEFEPIME HYDROCHLORIDE'? | Patterns of immunotherapy-induced pneumonitis in patients with non-small-cell lung cancer: a case series.
BACKGROUND
Immunotherapy has become an efficacious option in the management of solid organ malignancies. Immune-related adverse events including pneumonitis are well described and may be particularly of concern in ... | Intravenous (not otherwise specified) | DrugAdministrationRoute | CC BY | 34215343 | 19,628,465 | 2021-07-03 |
What was the administration route of drug 'CYCLOPHOSPHAMIDE'? | Patterns of immunotherapy-induced pneumonitis in patients with non-small-cell lung cancer: a case series.
BACKGROUND
Immunotherapy has become an efficacious option in the management of solid organ malignancies. Immune-related adverse events including pneumonitis are well described and may be particularly of concern in ... | Intravenous (not otherwise specified) | DrugAdministrationRoute | CC BY | 34215343 | 19,663,969 | 2021-07-03 |
What was the administration route of drug 'MEROPENEM'? | Patterns of immunotherapy-induced pneumonitis in patients with non-small-cell lung cancer: a case series.
BACKGROUND
Immunotherapy has become an efficacious option in the management of solid organ malignancies. Immune-related adverse events including pneumonitis are well described and may be particularly of concern in ... | Intravenous (not otherwise specified) | DrugAdministrationRoute | CC BY | 34215343 | 19,663,969 | 2021-07-03 |
What was the administration route of drug 'METHYLPREDNISOLONE'? | Patterns of immunotherapy-induced pneumonitis in patients with non-small-cell lung cancer: a case series.
BACKGROUND
Immunotherapy has become an efficacious option in the management of solid organ malignancies. Immune-related adverse events including pneumonitis are well described and may be particularly of concern in ... | Intravenous (not otherwise specified) | DrugAdministrationRoute | CC BY | 34215343 | 19,628,465 | 2021-07-03 |
What was the administration route of drug 'PREDNISOLONE'? | Patterns of immunotherapy-induced pneumonitis in patients with non-small-cell lung cancer: a case series.
BACKGROUND
Immunotherapy has become an efficacious option in the management of solid organ malignancies. Immune-related adverse events including pneumonitis are well described and may be particularly of concern in ... | Oral | DrugAdministrationRoute | CC BY | 34215343 | 19,663,969 | 2021-07-03 |
What was the administration route of drug 'SULFAMETHOXAZOLE\TRIMETHOPRIM'? | Patterns of immunotherapy-induced pneumonitis in patients with non-small-cell lung cancer: a case series.
BACKGROUND
Immunotherapy has become an efficacious option in the management of solid organ malignancies. Immune-related adverse events including pneumonitis are well described and may be particularly of concern in ... | Intravenous (not otherwise specified) | DrugAdministrationRoute | CC BY | 34215343 | 19,628,465 | 2021-07-03 |
What was the outcome of reaction 'Hypoxia'? | Patterns of immunotherapy-induced pneumonitis in patients with non-small-cell lung cancer: a case series.
BACKGROUND
Immunotherapy has become an efficacious option in the management of solid organ malignancies. Immune-related adverse events including pneumonitis are well described and may be particularly of concern in ... | Fatal | ReactionOutcome | CC BY | 34215343 | 19,635,780 | 2021-07-03 |
What was the outcome of reaction 'Immune-mediated lung disease'? | Patterns of immunotherapy-induced pneumonitis in patients with non-small-cell lung cancer: a case series.
BACKGROUND
Immunotherapy has become an efficacious option in the management of solid organ malignancies. Immune-related adverse events including pneumonitis are well described and may be particularly of concern in ... | Fatal | ReactionOutcome | CC BY | 34215343 | 19,635,780 | 2021-07-03 |
What was the outcome of reaction 'Pneumonitis'? | Patterns of immunotherapy-induced pneumonitis in patients with non-small-cell lung cancer: a case series.
BACKGROUND
Immunotherapy has become an efficacious option in the management of solid organ malignancies. Immune-related adverse events including pneumonitis are well described and may be particularly of concern in ... | Fatal | ReactionOutcome | CC BY | 34215343 | 19,663,973 | 2021-07-03 |
What was the outcome of reaction 'Rebound effect'? | Patterns of immunotherapy-induced pneumonitis in patients with non-small-cell lung cancer: a case series.
BACKGROUND
Immunotherapy has become an efficacious option in the management of solid organ malignancies. Immune-related adverse events including pneumonitis are well described and may be particularly of concern in ... | Fatal | ReactionOutcome | CC BY | 34215343 | 19,635,780 | 2021-07-03 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Arthropathy'. | Early rise in brain damage markers and high ICOS expression in CD4+ and CD8+ T cells during checkpoint inhibitor-induced encephalomyelitis.
We report a case of rapid eradication of melanoma brain metastases and simultaneous near-fatal encephalomyelitis following double immune checkpoint blockade. Brain damage marker S-... | NIVOLUMAB | DrugsGivenReaction | CC BY | 34215689 | 19,609,392 | 2021-07 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Encephalomyelitis'. | Early rise in brain damage markers and high ICOS expression in CD4+ and CD8+ T cells during checkpoint inhibitor-induced encephalomyelitis.
We report a case of rapid eradication of melanoma brain metastases and simultaneous near-fatal encephalomyelitis following double immune checkpoint blockade. Brain damage marker S-... | IPILIMUMAB, NIVOLUMAB | DrugsGivenReaction | CC BY | 34215689 | 19,604,999 | 2021-07 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Gastrointestinal disorder'. | Early rise in brain damage markers and high ICOS expression in CD4+ and CD8+ T cells during checkpoint inhibitor-induced encephalomyelitis.
We report a case of rapid eradication of melanoma brain metastases and simultaneous near-fatal encephalomyelitis following double immune checkpoint blockade. Brain damage marker S-... | NIVOLUMAB | DrugsGivenReaction | CC BY | 34215689 | 19,617,882 | 2021-07 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Muscle disorder'. | Early rise in brain damage markers and high ICOS expression in CD4+ and CD8+ T cells during checkpoint inhibitor-induced encephalomyelitis.
We report a case of rapid eradication of melanoma brain metastases and simultaneous near-fatal encephalomyelitis following double immune checkpoint blockade. Brain damage marker S-... | NIVOLUMAB | DrugsGivenReaction | CC BY | 34215689 | 19,609,392 | 2021-07 |
What was the dosage of drug 'IPILIMUMAB'? | Early rise in brain damage markers and high ICOS expression in CD4+ and CD8+ T cells during checkpoint inhibitor-induced encephalomyelitis.
We report a case of rapid eradication of melanoma brain metastases and simultaneous near-fatal encephalomyelitis following double immune checkpoint blockade. Brain damage marker S-... | 3 MILLIGRAM/KILOGRAM, Q3WK | DrugDosageText | CC BY | 34215689 | 19,604,999 | 2021-07 |
What was the dosage of drug 'NIVOLUMAB'? | Early rise in brain damage markers and high ICOS expression in CD4+ and CD8+ T cells during checkpoint inhibitor-induced encephalomyelitis.
We report a case of rapid eradication of melanoma brain metastases and simultaneous near-fatal encephalomyelitis following double immune checkpoint blockade. Brain damage marker S-... | 1 MILLIGRAM/KILOGRAM | DrugDosageText | CC BY | 34215689 | 19,604,999 | 2021-07 |
What was the outcome of reaction 'Encephalomyelitis'? | Early rise in brain damage markers and high ICOS expression in CD4+ and CD8+ T cells during checkpoint inhibitor-induced encephalomyelitis.
We report a case of rapid eradication of melanoma brain metastases and simultaneous near-fatal encephalomyelitis following double immune checkpoint blockade. Brain damage marker S-... | Recovered | ReactionOutcome | CC BY | 34215689 | 19,604,999 | 2021-07 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Rhegmatogenous retinal detachment'. | Intravitreal injection associated rhegmatogenous retinal detachment: outcomes of a European analysis.
OBJECTIVE
As the number of intravitreal injections (IVI) increases annually, this study aimed to assess the anatomical and functional outcomes following rhegmatogenous retinal detachment (RRD) surgery for IVI-associate... | AFLIBERCEPT, BEVACIZUMAB, DEXAMETHASONE, FLUOCINOLONE ACETONIDE, OCRIPLASMIN, RANIBIZUMAB | DrugsGivenReaction | CC BY | 34216254 | 20,363,932 | 2021-12 |
What was the administration route of drug 'AFLIBERCEPT'? | Intravitreal injection associated rhegmatogenous retinal detachment: outcomes of a European analysis.
OBJECTIVE
As the number of intravitreal injections (IVI) increases annually, this study aimed to assess the anatomical and functional outcomes following rhegmatogenous retinal detachment (RRD) surgery for IVI-associate... | Other | DrugAdministrationRoute | CC BY | 34216254 | 20,363,932 | 2021-12 |
What was the administration route of drug 'BEVACIZUMAB'? | Intravitreal injection associated rhegmatogenous retinal detachment: outcomes of a European analysis.
OBJECTIVE
As the number of intravitreal injections (IVI) increases annually, this study aimed to assess the anatomical and functional outcomes following rhegmatogenous retinal detachment (RRD) surgery for IVI-associate... | Other | DrugAdministrationRoute | CC BY | 34216254 | 20,363,932 | 2021-12 |
What was the administration route of drug 'OCRIPLASMIN'? | Intravitreal injection associated rhegmatogenous retinal detachment: outcomes of a European analysis.
OBJECTIVE
As the number of intravitreal injections (IVI) increases annually, this study aimed to assess the anatomical and functional outcomes following rhegmatogenous retinal detachment (RRD) surgery for IVI-associate... | Other | DrugAdministrationRoute | CC BY | 34216254 | 20,363,932 | 2021-12 |
What was the administration route of drug 'RANIBIZUMAB'? | Intravitreal injection associated rhegmatogenous retinal detachment: outcomes of a European analysis.
OBJECTIVE
As the number of intravitreal injections (IVI) increases annually, this study aimed to assess the anatomical and functional outcomes following rhegmatogenous retinal detachment (RRD) surgery for IVI-associate... | Other | DrugAdministrationRoute | CC BY | 34216254 | 20,363,932 | 2021-12 |
What was the dosage of drug 'FLUOCINOLONE ACETONIDE'? | Intravitreal injection associated rhegmatogenous retinal detachment: outcomes of a European analysis.
OBJECTIVE
As the number of intravitreal injections (IVI) increases annually, this study aimed to assess the anatomical and functional outcomes following rhegmatogenous retinal detachment (RRD) surgery for IVI-associate... | IMPLANT | DrugDosageText | CC BY | 34216254 | 20,363,932 | 2021-12 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Acute kidney injury'. | Page kidney: Rare cause of acute kidney injury after complicated renal artery angioplasty.
The authors present a case of a patient who experienced a rare complication after attempted renal angioplasty and stenting, Page kidney. This patient presented with new onset hypertension secondary to bilateral renal artery steno... | AMLODIPINE BESYLATE, BISOPROLOL, CLONIDINE, PERINDOPRIL | DrugsGivenReaction | CC BY | 34216535 | 19,845,191 | 2021-08 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Blood creatinine increased'. | Page kidney: Rare cause of acute kidney injury after complicated renal artery angioplasty.
The authors present a case of a patient who experienced a rare complication after attempted renal angioplasty and stenting, Page kidney. This patient presented with new onset hypertension secondary to bilateral renal artery steno... | AMLODIPINE BESYLATE, BISOPROLOL, CLONIDINE, PERINDOPRIL | DrugsGivenReaction | CC BY | 34216535 | 19,836,211 | 2021-08 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Drug ineffective'. | Page kidney: Rare cause of acute kidney injury after complicated renal artery angioplasty.
The authors present a case of a patient who experienced a rare complication after attempted renal angioplasty and stenting, Page kidney. This patient presented with new onset hypertension secondary to bilateral renal artery steno... | AMLODIPINE BESYLATE, BISOPROLOL, CLONIDINE, PERINDOPRIL | DrugsGivenReaction | CC BY | 34216535 | 19,845,191 | 2021-08 |
What was the outcome of reaction 'Acute kidney injury'? | Page kidney: Rare cause of acute kidney injury after complicated renal artery angioplasty.
The authors present a case of a patient who experienced a rare complication after attempted renal angioplasty and stenting, Page kidney. This patient presented with new onset hypertension secondary to bilateral renal artery steno... | Recovering | ReactionOutcome | CC BY | 34216535 | 19,845,191 | 2021-08 |
What was the outcome of reaction 'Blood creatinine increased'? | Page kidney: Rare cause of acute kidney injury after complicated renal artery angioplasty.
The authors present a case of a patient who experienced a rare complication after attempted renal angioplasty and stenting, Page kidney. This patient presented with new onset hypertension secondary to bilateral renal artery steno... | Recovered | ReactionOutcome | CC BY | 34216535 | 19,836,211 | 2021-08 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Drug ineffective'. | Outcome of immune checkpoint inhibitors in metastatic renal cell carcinoma across different treatment lines.
Immune checkpoint inhibitors (ICIs) have led to a paradigm change in the management of metastatic renal cell carcinoma (mRCC). Prospective trials have focused on ICI treatment in the first or second line. The ai... | AXITINIB, CABOZANTINIB, EVEROLIMUS, LENVATINIB, NIVOLUMAB, SUNITINIB | DrugsGivenReaction | CC BY-NC-ND | 34217917 | 20,739,694 | 2021-08 |
What was the dosage of drug 'EVEROLIMUS'? | Outcome of immune checkpoint inhibitors in metastatic renal cell carcinoma across different treatment lines.
Immune checkpoint inhibitors (ICIs) have led to a paradigm change in the management of metastatic renal cell carcinoma (mRCC). Prospective trials have focused on ICI treatment in the first or second line. The ai... | UNK; AS FOURTH-LINE THERAPY WITH LENVATINIB | DrugDosageText | CC BY-NC-ND | 34217917 | 20,739,694 | 2021-08 |
What was the dosage of drug 'LENVATINIB'? | Outcome of immune checkpoint inhibitors in metastatic renal cell carcinoma across different treatment lines.
Immune checkpoint inhibitors (ICIs) have led to a paradigm change in the management of metastatic renal cell carcinoma (mRCC). Prospective trials have focused on ICI treatment in the first or second line. The ai... | UNK; AS THE FOURTH-LINE THERAPY WITH EVEROLIMUS. | DrugDosageText | CC BY-NC-ND | 34217917 | 20,739,694 | 2021-08 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Drug ineffective'. | Anorectal Abscess in a Patient with Neutropenia and Refractory Acute Myeloid Leukemia: To Operate or not to Operate?
BACKGROUND Anorectal infections occur in 5% to 9% of patients with hematological malignancies, including acute myeloid leukemia, and cause febrile neutropenia and sepsis. Surgical treatments of anorectal... | CYTARABINE, DAUNORUBICIN, DORIPENEM, HUMAN IMMUNOGLOBULIN G, VANCOMYCIN | DrugsGivenReaction | CC BY-NC-ND | 34218249 | 20,089,824 | 2021-07-04 |
What was the administration route of drug 'CYTARABINE'? | Anorectal Abscess in a Patient with Neutropenia and Refractory Acute Myeloid Leukemia: To Operate or not to Operate?
BACKGROUND Anorectal infections occur in 5% to 9% of patients with hematological malignancies, including acute myeloid leukemia, and cause febrile neutropenia and sepsis. Surgical treatments of anorectal... | Intravenous (not otherwise specified) | DrugAdministrationRoute | CC BY-NC-ND | 34218249 | 20,089,824 | 2021-07-04 |
What was the administration route of drug 'DAUNORUBICIN'? | Anorectal Abscess in a Patient with Neutropenia and Refractory Acute Myeloid Leukemia: To Operate or not to Operate?
BACKGROUND Anorectal infections occur in 5% to 9% of patients with hematological malignancies, including acute myeloid leukemia, and cause febrile neutropenia and sepsis. Surgical treatments of anorectal... | Intravenous (not otherwise specified) | DrugAdministrationRoute | CC BY-NC-ND | 34218249 | 20,089,824 | 2021-07-04 |
What was the administration route of drug 'DORIPENEM'? | Anorectal Abscess in a Patient with Neutropenia and Refractory Acute Myeloid Leukemia: To Operate or not to Operate?
BACKGROUND Anorectal infections occur in 5% to 9% of patients with hematological malignancies, including acute myeloid leukemia, and cause febrile neutropenia and sepsis. Surgical treatments of anorectal... | Intravenous (not otherwise specified) | DrugAdministrationRoute | CC BY-NC-ND | 34218249 | 20,089,824 | 2021-07-04 |
What was the administration route of drug 'HUMAN IMMUNOGLOBULIN G'? | Anorectal Abscess in a Patient with Neutropenia and Refractory Acute Myeloid Leukemia: To Operate or not to Operate?
BACKGROUND Anorectal infections occur in 5% to 9% of patients with hematological malignancies, including acute myeloid leukemia, and cause febrile neutropenia and sepsis. Surgical treatments of anorectal... | Intravenous (not otherwise specified) | DrugAdministrationRoute | CC BY-NC-ND | 34218249 | 20,089,824 | 2021-07-04 |
What was the administration route of drug 'VANCOMYCIN'? | Anorectal Abscess in a Patient with Neutropenia and Refractory Acute Myeloid Leukemia: To Operate or not to Operate?
BACKGROUND Anorectal infections occur in 5% to 9% of patients with hematological malignancies, including acute myeloid leukemia, and cause febrile neutropenia and sepsis. Surgical treatments of anorectal... | Intravenous (not otherwise specified) | DrugAdministrationRoute | CC BY-NC-ND | 34218249 | 20,089,824 | 2021-07-04 |
What was the dosage of drug 'VANCOMYCIN'? | Anorectal Abscess in a Patient with Neutropenia and Refractory Acute Myeloid Leukemia: To Operate or not to Operate?
BACKGROUND Anorectal infections occur in 5% to 9% of patients with hematological malignancies, including acute myeloid leukemia, and cause febrile neutropenia and sepsis. Surgical treatments of anorectal... | 1 GRAM, BID | DrugDosageText | CC BY-NC-ND | 34218249 | 20,089,824 | 2021-07-04 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Acute graft versus host disease in intestine'. | Steroid-refractory chronic graft-versus-host disease: treatment options and patient management.
Chronic graft-versus-host disease (cGVHD) is one of the major causes of late mortality after allogenic hematopoietic stem cell transplantation. Moderate-to-severe cGVHD is associated with poor health-related quality of life ... | CYCLOSPORINE, MYCOPHENOLATE MOFETIL | DrugsGivenReaction | CC BY | 34218265 | 20,070,496 | 2021-09 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Acute graft versus host disease in skin'. | Steroid-refractory chronic graft-versus-host disease: treatment options and patient management.
Chronic graft-versus-host disease (cGVHD) is one of the major causes of late mortality after allogenic hematopoietic stem cell transplantation. Moderate-to-severe cGVHD is associated with poor health-related quality of life ... | CYCLOSPORINE, MYCOPHENOLATE MOFETIL | DrugsGivenReaction | CC BY | 34218265 | 20,070,496 | 2021-09 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Acute graft versus host disease'. | Steroid-refractory chronic graft-versus-host disease: treatment options and patient management.
Chronic graft-versus-host disease (cGVHD) is one of the major causes of late mortality after allogenic hematopoietic stem cell transplantation. Moderate-to-severe cGVHD is associated with poor health-related quality of life ... | CYCLOSPORINE, MYCOPHENOLATE MOFETIL, PREDNISONE, SIROLIMUS | DrugsGivenReaction | CC BY | 34218265 | 19,991,932 | 2021-09 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Chronic graft versus host disease in eye'. | Steroid-refractory chronic graft-versus-host disease: treatment options and patient management.
Chronic graft-versus-host disease (cGVHD) is one of the major causes of late mortality after allogenic hematopoietic stem cell transplantation. Moderate-to-severe cGVHD is associated with poor health-related quality of life ... | CYCLOSPORINE, PREDNISONE | DrugsGivenReaction | CC BY | 34218265 | 20,007,530 | 2021-09 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Chronic graft versus host disease in skin'. | Steroid-refractory chronic graft-versus-host disease: treatment options and patient management.
Chronic graft-versus-host disease (cGVHD) is one of the major causes of late mortality after allogenic hematopoietic stem cell transplantation. Moderate-to-severe cGVHD is associated with poor health-related quality of life ... | CYCLOSPORINE, PREDNISONE | DrugsGivenReaction | CC BY | 34218265 | 20,007,530 | 2021-09 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Chronic graft versus host disease oral'. | Steroid-refractory chronic graft-versus-host disease: treatment options and patient management.
Chronic graft-versus-host disease (cGVHD) is one of the major causes of late mortality after allogenic hematopoietic stem cell transplantation. Moderate-to-severe cGVHD is associated with poor health-related quality of life ... | CYCLOSPORINE, PREDNISONE | DrugsGivenReaction | CC BY | 34218265 | 20,007,530 | 2021-09 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Chronic graft versus host disease'. | Steroid-refractory chronic graft-versus-host disease: treatment options and patient management.
Chronic graft-versus-host disease (cGVHD) is one of the major causes of late mortality after allogenic hematopoietic stem cell transplantation. Moderate-to-severe cGVHD is associated with poor health-related quality of life ... | CYCLOSPORINE, MYCOPHENOLATE MOFETIL | DrugsGivenReaction | CC BY | 34218265 | 20,070,496 | 2021-09 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Cytomegalovirus infection reactivation'. | Steroid-refractory chronic graft-versus-host disease: treatment options and patient management.
Chronic graft-versus-host disease (cGVHD) is one of the major causes of late mortality after allogenic hematopoietic stem cell transplantation. Moderate-to-severe cGVHD is associated with poor health-related quality of life ... | AZITHROMYCIN ANHYDROUS, FLUTICASONE, MONTELUKAST SODIUM, PREDNISONE, TACROLIMUS | DrugsGivenReaction | CC BY | 34218265 | 19,989,823 | 2021-09 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Disease progression'. | Steroid-refractory chronic graft-versus-host disease: treatment options and patient management.
Chronic graft-versus-host disease (cGVHD) is one of the major causes of late mortality after allogenic hematopoietic stem cell transplantation. Moderate-to-severe cGVHD is associated with poor health-related quality of life ... | AZITHROMYCIN ANHYDROUS, FLUTICASONE, MONTELUKAST SODIUM, PREDNISONE, TACROLIMUS | DrugsGivenReaction | CC BY | 34218265 | 19,989,823 | 2021-09 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Product use in unapproved indication'. | Steroid-refractory chronic graft-versus-host disease: treatment options and patient management.
Chronic graft-versus-host disease (cGVHD) is one of the major causes of late mortality after allogenic hematopoietic stem cell transplantation. Moderate-to-severe cGVHD is associated with poor health-related quality of life ... | CYCLOSPORINE, MYCOPHENOLATE MOFETIL | DrugsGivenReaction | CC BY | 34218265 | 20,070,496 | 2021-09 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Substance-induced psychotic disorder'. | Steroid-refractory chronic graft-versus-host disease: treatment options and patient management.
Chronic graft-versus-host disease (cGVHD) is one of the major causes of late mortality after allogenic hematopoietic stem cell transplantation. Moderate-to-severe cGVHD is associated with poor health-related quality of life ... | CYCLOSPORINE, MYCOPHENOLATE MOFETIL, PREDNISONE, SIROLIMUS | DrugsGivenReaction | CC BY | 34218265 | 19,991,932 | 2021-09 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Drug intolerance'. | Recurrent Priapism From Cabergoline and Bromocriptine in a Hypogonadal Man With Prolactinoma.
Dopamine agonists are generally well tolerated and represent the first-line therapy for prolactinomas. We report a case of a 20-year-old man with a macroprolactinoma who developed recurrent priapism with cabergoline and bromoc... | BROMOCRIPTINE, CABERGOLINE | DrugsGivenReaction | CC BY-NC | 34218714 | 20,724,963 | 2021 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Priapism'. | Recurrent Priapism From Cabergoline and Bromocriptine in a Hypogonadal Man With Prolactinoma.
Dopamine agonists are generally well tolerated and represent the first-line therapy for prolactinomas. We report a case of a 20-year-old man with a macroprolactinoma who developed recurrent priapism with cabergoline and bromoc... | BROMOCRIPTINE, CABERGOLINE | DrugsGivenReaction | CC BY-NC | 34218714 | 19,900,924 | 2021 |
What was the outcome of reaction 'Priapism'? | Recurrent Priapism From Cabergoline and Bromocriptine in a Hypogonadal Man With Prolactinoma.
Dopamine agonists are generally well tolerated and represent the first-line therapy for prolactinomas. We report a case of a 20-year-old man with a macroprolactinoma who developed recurrent priapism with cabergoline and bromoc... | Recovered | ReactionOutcome | CC BY-NC | 34218714 | 19,900,924 | 2021 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Meningitis'. | Aseptic Meningitis-retention Syndrome Associated with Tocilizumab in a Patient with Idiopathic Multicentric Castleman Disease.
This is the first report of tocilizumab-associated meningitis-retention syndrome in a patient with idiopathic multicentric Castleman disease. A 57-year-old man presented with headache, nuchal r... | CELECOXIB, MEROPENEM, PREDNISOLONE | DrugsGivenReaction | CC BY-NC-ND | 34219105 | 20,683,752 | 2021-07-03 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Therapeutic product effect incomplete'. | Aseptic Meningitis-retention Syndrome Associated with Tocilizumab in a Patient with Idiopathic Multicentric Castleman Disease.
This is the first report of tocilizumab-associated meningitis-retention syndrome in a patient with idiopathic multicentric Castleman disease. A 57-year-old man presented with headache, nuchal r... | ACYCLOVIR, CEFTRIAXONE, CELECOXIB, MEROPENEM, PREDNISOLONE, TOCILIZUMAB | DrugsGivenReaction | CC BY-NC-ND | 34219105 | 20,336,554 | 2021-07-03 |
What was the administration route of drug 'ACYCLOVIR'? | Aseptic Meningitis-retention Syndrome Associated with Tocilizumab in a Patient with Idiopathic Multicentric Castleman Disease.
This is the first report of tocilizumab-associated meningitis-retention syndrome in a patient with idiopathic multicentric Castleman disease. A 57-year-old man presented with headache, nuchal r... | Intravenous (not otherwise specified) | DrugAdministrationRoute | CC BY-NC-ND | 34219105 | 20,336,554 | 2021-07-03 |
What was the administration route of drug 'PREDNISOLONE'? | Aseptic Meningitis-retention Syndrome Associated with Tocilizumab in a Patient with Idiopathic Multicentric Castleman Disease.
This is the first report of tocilizumab-associated meningitis-retention syndrome in a patient with idiopathic multicentric Castleman disease. A 57-year-old man presented with headache, nuchal r... | Oral | DrugAdministrationRoute | CC BY-NC-ND | 34219105 | 20,336,554 | 2021-07-03 |
What was the dosage of drug 'ACYCLOVIR'? | Aseptic Meningitis-retention Syndrome Associated with Tocilizumab in a Patient with Idiopathic Multicentric Castleman Disease.
This is the first report of tocilizumab-associated meningitis-retention syndrome in a patient with idiopathic multicentric Castleman disease. A 57-year-old man presented with headache, nuchal r... | 625 MILLIGRAM, TID | DrugDosageText | CC BY-NC-ND | 34219105 | 20,336,554 | 2021-07-03 |
What was the dosage of drug 'CEFTRIAXONE'? | Aseptic Meningitis-retention Syndrome Associated with Tocilizumab in a Patient with Idiopathic Multicentric Castleman Disease.
This is the first report of tocilizumab-associated meningitis-retention syndrome in a patient with idiopathic multicentric Castleman disease. A 57-year-old man presented with headache, nuchal r... | 2 GRAM, QD, FOR 10 DAYS | DrugDosageText | CC BY-NC-ND | 34219105 | 20,336,554 | 2021-07-03 |
What was the dosage of drug 'TOCILIZUMAB'? | Aseptic Meningitis-retention Syndrome Associated with Tocilizumab in a Patient with Idiopathic Multicentric Castleman Disease.
This is the first report of tocilizumab-associated meningitis-retention syndrome in a patient with idiopathic multicentric Castleman disease. A 57-year-old man presented with headache, nuchal r... | 8 MG/KG/MONTH | DrugDosageText | CC BY-NC-ND | 34219105 | 20,336,554 | 2021-07-03 |
What was the outcome of reaction 'Meningitis aseptic'? | Aseptic Meningitis-retention Syndrome Associated with Tocilizumab in a Patient with Idiopathic Multicentric Castleman Disease.
This is the first report of tocilizumab-associated meningitis-retention syndrome in a patient with idiopathic multicentric Castleman disease. A 57-year-old man presented with headache, nuchal r... | Recovering | ReactionOutcome | CC BY-NC-ND | 34219105 | 20,336,554 | 2021-07-03 |
What was the outcome of reaction 'Urinary retention'? | Aseptic Meningitis-retention Syndrome Associated with Tocilizumab in a Patient with Idiopathic Multicentric Castleman Disease.
This is the first report of tocilizumab-associated meningitis-retention syndrome in a patient with idiopathic multicentric Castleman disease. A 57-year-old man presented with headache, nuchal r... | Recovering | ReactionOutcome | CC BY-NC-ND | 34219105 | 20,336,554 | 2021-07-03 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Chest injury'. | Long-Term Prostate-Specific Antigen Response on a Low-Dose Cabazitaxel Regimen for Metastatic Castration-Resistant Prostate Cancer: A Case Report.
BACKGROUND Cabazitaxel is a second-generation taxane approved for patients with metastatic castration-resistant prostate cancer (CRPC). Although cabazitaxel improves overall... | CABAZITAXEL, DENOSUMAB, DOCETAXEL, PEGFILGRASTIM, UNSPECIFIED INGREDIENT | DrugsGivenReaction | CC BY-NC-ND | 34219125 | 19,663,608 | 2021-07-05 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Drug ineffective'. | Long-Term Prostate-Specific Antigen Response on a Low-Dose Cabazitaxel Regimen for Metastatic Castration-Resistant Prostate Cancer: A Case Report.
BACKGROUND Cabazitaxel is a second-generation taxane approved for patients with metastatic castration-resistant prostate cancer (CRPC). Although cabazitaxel improves overall... | ABIRATERONE ACETATE, BICALUTAMIDE, CABAZITAXEL, DENOSUMAB, DOCETAXEL, ENZALUTAMIDE, ESTRAMUSTINE, FLUTAMIDE, PEGFILGRASTIM, PREDNISONE | DrugsGivenReaction | CC BY-NC-ND | 34219125 | 19,705,881 | 2021-07-05 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Osteonecrosis'. | Long-Term Prostate-Specific Antigen Response on a Low-Dose Cabazitaxel Regimen for Metastatic Castration-Resistant Prostate Cancer: A Case Report.
BACKGROUND Cabazitaxel is a second-generation taxane approved for patients with metastatic castration-resistant prostate cancer (CRPC). Although cabazitaxel improves overall... | CABAZITAXEL, DENOSUMAB, DOCETAXEL, PEGFILGRASTIM, UNSPECIFIED INGREDIENT | DrugsGivenReaction | CC BY-NC-ND | 34219125 | 19,663,608 | 2021-07-05 |
What was the administration route of drug 'DENOSUMAB'? | Long-Term Prostate-Specific Antigen Response on a Low-Dose Cabazitaxel Regimen for Metastatic Castration-Resistant Prostate Cancer: A Case Report.
BACKGROUND Cabazitaxel is a second-generation taxane approved for patients with metastatic castration-resistant prostate cancer (CRPC). Although cabazitaxel improves overall... | Subcutaneous | DrugAdministrationRoute | CC BY-NC-ND | 34219125 | 19,663,608 | 2021-07-05 |
What was the administration route of drug 'DOCETAXEL'? | Long-Term Prostate-Specific Antigen Response on a Low-Dose Cabazitaxel Regimen for Metastatic Castration-Resistant Prostate Cancer: A Case Report.
BACKGROUND Cabazitaxel is a second-generation taxane approved for patients with metastatic castration-resistant prostate cancer (CRPC). Although cabazitaxel improves overall... | Intravenous (not otherwise specified) | DrugAdministrationRoute | CC BY-NC-ND | 34219125 | 19,663,608 | 2021-07-05 |
What was the dosage of drug 'DENOSUMAB'? | Long-Term Prostate-Specific Antigen Response on a Low-Dose Cabazitaxel Regimen for Metastatic Castration-Resistant Prostate Cancer: A Case Report.
BACKGROUND Cabazitaxel is a second-generation taxane approved for patients with metastatic castration-resistant prostate cancer (CRPC). Although cabazitaxel improves overall... | 120 MILLIGRAM, Q4WK | DrugDosageText | CC BY-NC-ND | 34219125 | 19,663,608 | 2021-07-05 |
What was the dosage of drug 'DOCETAXEL'? | Long-Term Prostate-Specific Antigen Response on a Low-Dose Cabazitaxel Regimen for Metastatic Castration-Resistant Prostate Cancer: A Case Report.
BACKGROUND Cabazitaxel is a second-generation taxane approved for patients with metastatic castration-resistant prostate cancer (CRPC). Although cabazitaxel improves overall... | 70 MG/M2, ONCE EVERY 3 WK | DrugDosageText | CC BY-NC-ND | 34219125 | 19,663,608 | 2021-07-05 |
What was the outcome of reaction 'Neutropenia'? | Long-Term Prostate-Specific Antigen Response on a Low-Dose Cabazitaxel Regimen for Metastatic Castration-Resistant Prostate Cancer: A Case Report.
BACKGROUND Cabazitaxel is a second-generation taxane approved for patients with metastatic castration-resistant prostate cancer (CRPC). Although cabazitaxel improves overall... | Recovered | ReactionOutcome | CC BY-NC-ND | 34219125 | 19,705,881 | 2021-07-05 |
What was the outcome of reaction 'Thrombocytopenia'? | Long-Term Prostate-Specific Antigen Response on a Low-Dose Cabazitaxel Regimen for Metastatic Castration-Resistant Prostate Cancer: A Case Report.
BACKGROUND Cabazitaxel is a second-generation taxane approved for patients with metastatic castration-resistant prostate cancer (CRPC). Although cabazitaxel improves overall... | Recovered | ReactionOutcome | CC BY-NC-ND | 34219125 | 19,705,881 | 2021-07-05 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Exposure during pregnancy'. | Luteal phase deficiency during the early trimester in a case with secondary hypopituitarism following craniopharyngioma resection.
A 31-year-old woman, who had been diagnosed with craniopharyngioma (CP) at the age of 13, suffered secondary hypopituitarism after two surgical resections of CP, receiving supplement of lev... | CORTISONE, DYDROGESTERONE, ESTRADIOL VALERATE, GONADOTROPHIN, CHORIONIC, LEVOTHYROXINE | DrugsGivenReaction | CC BY-NC-ND | 34219314 | 20,126,738 | 2021-09 |
What was the dosage of drug 'GONADOTROPHIN, CHORIONIC'? | Luteal phase deficiency during the early trimester in a case with secondary hypopituitarism following craniopharyngioma resection.
A 31-year-old woman, who had been diagnosed with craniopharyngioma (CP) at the age of 13, suffered secondary hypopituitarism after two surgical resections of CP, receiving supplement of lev... | 10000 INTERNATIONAL UNIT | DrugDosageText | CC BY-NC-ND | 34219314 | 20,126,738 | 2021-09 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Immune-mediated myositis'. | Statin-Induced Autoimmune Necrotizing Myopathy.
Statin therapy is a widely prescribed medication class for hypercholesterolemia. In statin-induced autoimmune myopathy, genetically predisposed and at-risk patients can develop antibodies against hydroxy-3-methylglutaryl-CoA reductase (HMGCR), the key enzyme in the produc... | ATORVASTATIN, MELOXICAM | DrugsGivenReaction | CC BY-NC | 34219515 | 19,728,218 | 2021 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Rhabdomyolysis'. | Statin-Induced Autoimmune Necrotizing Myopathy.
Statin therapy is a widely prescribed medication class for hypercholesterolemia. In statin-induced autoimmune myopathy, genetically predisposed and at-risk patients can develop antibodies against hydroxy-3-methylglutaryl-CoA reductase (HMGCR), the key enzyme in the produc... | ATORVASTATIN, MELOXICAM | DrugsGivenReaction | CC BY-NC | 34219515 | 19,728,218 | 2021 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Transaminases increased'. | Statin-Induced Autoimmune Necrotizing Myopathy.
Statin therapy is a widely prescribed medication class for hypercholesterolemia. In statin-induced autoimmune myopathy, genetically predisposed and at-risk patients can develop antibodies against hydroxy-3-methylglutaryl-CoA reductase (HMGCR), the key enzyme in the produc... | ATORVASTATIN, MELOXICAM | DrugsGivenReaction | CC BY-NC | 34219515 | 19,728,218 | 2021 |
What was the outcome of reaction 'Immune-mediated myositis'? | Statin-Induced Autoimmune Necrotizing Myopathy.
Statin therapy is a widely prescribed medication class for hypercholesterolemia. In statin-induced autoimmune myopathy, genetically predisposed and at-risk patients can develop antibodies against hydroxy-3-methylglutaryl-CoA reductase (HMGCR), the key enzyme in the produc... | Recovering | ReactionOutcome | CC BY-NC | 34219515 | 19,715,646 | 2021 |
What was the outcome of reaction 'Rhabdomyolysis'? | Statin-Induced Autoimmune Necrotizing Myopathy.
Statin therapy is a widely prescribed medication class for hypercholesterolemia. In statin-induced autoimmune myopathy, genetically predisposed and at-risk patients can develop antibodies against hydroxy-3-methylglutaryl-CoA reductase (HMGCR), the key enzyme in the produc... | Recovering | ReactionOutcome | CC BY-NC | 34219515 | 19,715,646 | 2021 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Adrenal insufficiency'. | Adrenal Insufficiency Secondary to Septic Shock in a Male Patient with Iatrogenic Cushing's Syndrome: 2 sides of the Same Coin?
Cushing's syndrome causes increased morbidity and mortality due to cardiovascular and infectious diseases. Exogenous Cushing's syndrome can render the adrenal glands unable to cope with severe... | AMLODIPINE BESYLATE\OLMESARTAN MEDOXOMIL, LEVOFLOXACIN, MESALAMINE, METHYLPREDNISOLONE, METRONIDAZOLE, PANTOPRAZOLE, PAROXETINE, PREDNISOLONE, SODIUM CHLORIDE | DrugsGivenReaction | CC BY-NC | 34220206 | 20,303,686 | 2021 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'False negative investigation result'. | Adrenal Insufficiency Secondary to Septic Shock in a Male Patient with Iatrogenic Cushing's Syndrome: 2 sides of the Same Coin?
Cushing's syndrome causes increased morbidity and mortality due to cardiovascular and infectious diseases. Exogenous Cushing's syndrome can render the adrenal glands unable to cope with severe... | AMLODIPINE BESYLATE\OLMESARTAN MEDOXOMIL, FLUCONAZOLE, HYDROCHLOROTHIAZIDE, HYDROCORTISONE, LEVOFLOXACIN, LINEZOLID, MESALAMINE, METHYLPREDNISOLONE, METRONIDAZOLE, NEBIVOLOL, NOREPINEPHRINE, PANTOPRAZOLE, PAROXETINE, PIPERACILLIN SODIUM\TAZOBACTAM SODIUM, PREDNISONE, SODIUM CHLORIDE | DrugsGivenReaction | CC BY-NC | 34220206 | 20,357,814 | 2021 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Haemoglobin decreased'. | Adrenal Insufficiency Secondary to Septic Shock in a Male Patient with Iatrogenic Cushing's Syndrome: 2 sides of the Same Coin?
Cushing's syndrome causes increased morbidity and mortality due to cardiovascular and infectious diseases. Exogenous Cushing's syndrome can render the adrenal glands unable to cope with severe... | AMLODIPINE BESYLATE\OLMESARTAN MEDOXOMIL, LEVOFLOXACIN, MESALAMINE, METHYLPREDNISOLONE, METRONIDAZOLE, PANTOPRAZOLE, PAROXETINE, PREDNISOLONE, SODIUM CHLORIDE | DrugsGivenReaction | CC BY-NC | 34220206 | 20,303,686 | 2021 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Hypertension'. | Adrenal Insufficiency Secondary to Septic Shock in a Male Patient with Iatrogenic Cushing's Syndrome: 2 sides of the Same Coin?
Cushing's syndrome causes increased morbidity and mortality due to cardiovascular and infectious diseases. Exogenous Cushing's syndrome can render the adrenal glands unable to cope with severe... | AMLODIPINE BESYLATE\OLMESARTAN MEDOXOMIL, LEVOFLOXACIN, MESALAMINE, METHYLPREDNISOLONE, METRONIDAZOLE, PANTOPRAZOLE, PAROXETINE, PREDNISOLONE, SODIUM CHLORIDE | DrugsGivenReaction | CC BY-NC | 34220206 | 20,303,686 | 2021 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Incorrect product administration duration'. | Adrenal Insufficiency Secondary to Septic Shock in a Male Patient with Iatrogenic Cushing's Syndrome: 2 sides of the Same Coin?
Cushing's syndrome causes increased morbidity and mortality due to cardiovascular and infectious diseases. Exogenous Cushing's syndrome can render the adrenal glands unable to cope with severe... | AMLODIPINE BESYLATE\OLMESARTAN MEDOXOMIL, LEVOFLOXACIN, MESALAMINE, METHYLPREDNISOLONE, METRONIDAZOLE, PANTOPRAZOLE, PAROXETINE, PREDNISOLONE, SODIUM CHLORIDE | DrugsGivenReaction | CC BY-NC | 34220206 | 20,303,686 | 2021 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Respiratory alkalosis'. | Adrenal Insufficiency Secondary to Septic Shock in a Male Patient with Iatrogenic Cushing's Syndrome: 2 sides of the Same Coin?
Cushing's syndrome causes increased morbidity and mortality due to cardiovascular and infectious diseases. Exogenous Cushing's syndrome can render the adrenal glands unable to cope with severe... | AMLODIPINE BESYLATE\OLMESARTAN MEDOXOMIL, LEVOFLOXACIN, MESALAMINE, METHYLPREDNISOLONE, METRONIDAZOLE, PANTOPRAZOLE, PAROXETINE, PREDNISOLONE, SODIUM CHLORIDE | DrugsGivenReaction | CC BY-NC | 34220206 | 20,303,686 | 2021 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Thoracic vertebral fracture'. | Adrenal Insufficiency Secondary to Septic Shock in a Male Patient with Iatrogenic Cushing's Syndrome: 2 sides of the Same Coin?
Cushing's syndrome causes increased morbidity and mortality due to cardiovascular and infectious diseases. Exogenous Cushing's syndrome can render the adrenal glands unable to cope with severe... | AMLODIPINE BESYLATE\OLMESARTAN MEDOXOMIL, LEVOFLOXACIN, MESALAMINE, METHYLPREDNISOLONE, METRONIDAZOLE, PANTOPRAZOLE, PAROXETINE, PREDNISOLONE, SODIUM CHLORIDE | DrugsGivenReaction | CC BY-NC | 34220206 | 20,303,686 | 2021 |
What was the administration route of drug 'HYDROCORTISONE'? | Adrenal Insufficiency Secondary to Septic Shock in a Male Patient with Iatrogenic Cushing's Syndrome: 2 sides of the Same Coin?
Cushing's syndrome causes increased morbidity and mortality due to cardiovascular and infectious diseases. Exogenous Cushing's syndrome can render the adrenal glands unable to cope with severe... | Intravenous (not otherwise specified) | DrugAdministrationRoute | CC BY-NC | 34220206 | 20,357,814 | 2021 |
What was the administration route of drug 'MESALAMINE'? | Adrenal Insufficiency Secondary to Septic Shock in a Male Patient with Iatrogenic Cushing's Syndrome: 2 sides of the Same Coin?
Cushing's syndrome causes increased morbidity and mortality due to cardiovascular and infectious diseases. Exogenous Cushing's syndrome can render the adrenal glands unable to cope with severe... | Oral | DrugAdministrationRoute | CC BY-NC | 34220206 | 20,357,814 | 2021 |
What was the administration route of drug 'METHYLPREDNISOLONE'? | Adrenal Insufficiency Secondary to Septic Shock in a Male Patient with Iatrogenic Cushing's Syndrome: 2 sides of the Same Coin?
Cushing's syndrome causes increased morbidity and mortality due to cardiovascular and infectious diseases. Exogenous Cushing's syndrome can render the adrenal glands unable to cope with severe... | Intravenous (not otherwise specified) | DrugAdministrationRoute | CC BY-NC | 34220206 | 20,357,814 | 2021 |
What was the administration route of drug 'PIPERACILLIN SODIUM\TAZOBACTAM SODIUM'? | Adrenal Insufficiency Secondary to Septic Shock in a Male Patient with Iatrogenic Cushing's Syndrome: 2 sides of the Same Coin?
Cushing's syndrome causes increased morbidity and mortality due to cardiovascular and infectious diseases. Exogenous Cushing's syndrome can render the adrenal glands unable to cope with severe... | Intravenous (not otherwise specified) | DrugAdministrationRoute | CC BY-NC | 34220206 | 20,357,814 | 2021 |
What was the administration route of drug 'PREDNISOLONE'? | Adrenal Insufficiency Secondary to Septic Shock in a Male Patient with Iatrogenic Cushing's Syndrome: 2 sides of the Same Coin?
Cushing's syndrome causes increased morbidity and mortality due to cardiovascular and infectious diseases. Exogenous Cushing's syndrome can render the adrenal glands unable to cope with severe... | Oral | DrugAdministrationRoute | CC BY-NC | 34220206 | 20,303,686 | 2021 |
What was the administration route of drug 'PREDNISONE'? | Adrenal Insufficiency Secondary to Septic Shock in a Male Patient with Iatrogenic Cushing's Syndrome: 2 sides of the Same Coin?
Cushing's syndrome causes increased morbidity and mortality due to cardiovascular and infectious diseases. Exogenous Cushing's syndrome can render the adrenal glands unable to cope with severe... | Oral | DrugAdministrationRoute | CC BY-NC | 34220206 | 20,357,814 | 2021 |
What was the administration route of drug 'SODIUM CHLORIDE'? | Adrenal Insufficiency Secondary to Septic Shock in a Male Patient with Iatrogenic Cushing's Syndrome: 2 sides of the Same Coin?
Cushing's syndrome causes increased morbidity and mortality due to cardiovascular and infectious diseases. Exogenous Cushing's syndrome can render the adrenal glands unable to cope with severe... | Intravenous (not otherwise specified) | DrugAdministrationRoute | CC BY-NC | 34220206 | 20,357,814 | 2021 |
What was the dosage of drug 'NOREPINEPHRINE'? | Adrenal Insufficiency Secondary to Septic Shock in a Male Patient with Iatrogenic Cushing's Syndrome: 2 sides of the Same Coin?
Cushing's syndrome causes increased morbidity and mortality due to cardiovascular and infectious diseases. Exogenous Cushing's syndrome can render the adrenal glands unable to cope with severe... | INFUSION 0.1 MCG/KG/MIN | DrugDosageText | CC BY-NC | 34220206 | 20,357,814 | 2021 |
What was the outcome of reaction 'Acute kidney injury'? | Adrenal Insufficiency Secondary to Septic Shock in a Male Patient with Iatrogenic Cushing's Syndrome: 2 sides of the Same Coin?
Cushing's syndrome causes increased morbidity and mortality due to cardiovascular and infectious diseases. Exogenous Cushing's syndrome can render the adrenal glands unable to cope with severe... | Recovered | ReactionOutcome | CC BY-NC | 34220206 | 20,357,814 | 2021 |
Subsets and Splits
No community queries yet
The top public SQL queries from the community will appear here once available.